The Trump administration intends to complete its safety review of an abortion drug by March 2027, government lawyers said in a court filing published late Wednesday, effectively punting it until after the midterm elections.
Oct 08 26October 08, 2026
Article at Bloomberg Law
The Trump administration violated spending law in withholding grant funds for the health quality research agency at the Department of Health and Human Services, a federal government watchdog agency found.
Oct 07 26October 07, 2026
Lawyers for the federal government said the court lacks jurisdiction to consider a lawsuit challenging its alleged lack of agency response on Havana Syndrome, a cluster of symptoms first documented at the US embassy in Cuba in 2016.
Oct 06 26October 06, 2026
Health and Human Services Secretary Robert F. Kennedy Jr. announced a new research initiative at the National Institutes of Health to study vaccine injuries on Monday, according to people familiar with the matter.
Oct 05 26October 05, 2026
Article at bloomberg.com
Florida Attorney General James Uthmeier filed a lawsuit against Pfizer Inc. alleging the drug company and its chief executive misled individuals about the safety of its Covid-19 vaccine.
Oct 01 26October 01, 2026
A federal judge granted an order preventing teen pregnancy prevention funding from lapsing while a lawsuit challenging Trump administration policy changes continues.
Sep 21 26September 21, 2026
A federal judge dismissed a challenge on which types of organizations would be eligible to federal family planning funds.
Sep 18 26September 18, 2026
The Federal Trade Commission and the Endocrine Society agreed to dismiss without prejudice the medical group’s lawsuit challenging a government investigation into its activities and communications promoting pediatric gender-affirming care.
Sep 17 26September 17, 2026
Researchers filed a lawsuit on Wednesday against the National Institutes of Health, challenging the agency’s cuts to thousands of medical research grants based on the Trump administration’s political priorities.
Sep 16 26September 16, 2026
Agencies are moving to give political appointees a bigger say in how grant money goes out the door, even as Congress has stalled the White House’s efforts to expand such authorities across the federal government.
Sep 10 26September 10, 2026
A federal appeals court questioned both its authority to act and the FDA’s processes in a red-state challenge to the agency’s rules allowing mail-order dispensing of the abortion drug mifepristone.
Sep 09 26September 09, 2026
The Department of Defense is attempting to redirect National Institute of Health money to bolster the Pentagon’s budget, according to the top Democrat on the House Appropriations Committee.
Sep 04 26September 04, 2026
A federal advisory panel voted on Thursday in favor of a new blueprint for autism policy despite objections from patient advocacy groups over the abbreviated timeline and drafting process.
Aug 27 26August 27, 2026
A recently overhauled federal advisory panel is set to consider a shift of resources for autism policy on Thursday, on the heels of the Trump administration’s renewed focus on an unproven link between vaccines and autism.
Aug 26 26August 26, 2026
The Federal Trade Commission and the American Academy of Pediatrics agreed to settle without prejudice the AAP’s lawsuit against the agency’s investigation into the group’s communications and promotion of gender-affirming care Monday.
Aug 24 26August 24, 2026
Health and Human Services Secretary Robert F. Kennedy Jr. took another step toward his promise to further loosen federal vaccine advice, seeking feedback on which vaccines should be recommended universally.
Aug 21 26August 21, 2026
A federal judge temporarily paused the Trump administration’s limits to a grant program designed to limit teen pregnancy, but stopped short of reinstating terminated grants.
Aug 19 26August 19, 2026
The Trump administration is seeking federal investigations into pediatric gender-affirming care at more than 200 hospitals and clinics.
Aug 13 26August 13, 2026
The Trump administration’s executive order seeking to split up when children should get a critical vaccine would pose a new range of hurdles for manufacturers, prompting questions on whether the industry will meet the demand.
Aug 11 26August 11, 2026
Built with Authory. Get your own portfolio now!